Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837665 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation
A Phase 1 study, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT03837665 is a Phase 1 study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT03837665, a Phase 1 study, was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
By doing this study, researchers hope to find out if platelet rich plasma (PRP) can heal holes in the eardrum as an alternative to surgery.
Interventions
- BIOLOGICAL Platelet Rich Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-05-02 |
| Est. Completion | 2019-10-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03837665
The ClinicalTrials.gov registry entry for NCT03837665 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Rich Plasma is the first listed.
NCT03837665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03837665 about?
NCT03837665 is a clinical study titled "Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation". By doing this study, researchers hope to find out if platelet rich plasma (PRP) can heal holes in the eardrum as an alternative to surgery.
What is the current status of trial NCT03837665?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2018-05-02. Estimated completion is 2019-10-29.
What interventions are being tested in trial NCT03837665?
The interventions under investigation include: Platelet Rich Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT03837665?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.